Acetohexamide (trade name Dymelor) is a first-generation sulfonylureamedication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.[1]
Oral hypoglycemic drugs, including acetohexamide, have been associated with increased cardiovascular mortality. Qualified healthcare professionals should consulted for possible risks, benefits, and alternatives of using this drug for treatment of type 2 diabetes.[3]
References
^Montgomery DA (October 1964). "Current Therapeutics. CCII. Acetohexamide". The Practitioner. 193: 555–60. PMID14216839.
Recent Comments